Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04921527
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2021-06-03
Brief Title:
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Sponsor:
Chipscreen Biosciences Ltd
Organization:
Chipscreen Biosciences Ltd
Organization Data
Organization:
Chipscreen Biosciences Ltd
Class:
INDUSTRY
Study ID:
CAR301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chipscreen Biosciences Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None